What Is Silicon Dioxide? Simple Definition, Formula and Everyday Examples

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Silica Powder Malaysia: Suppliers, Grades and Sourcing Options
  • Keywords: silica nanoparticles
  • Published: 2026-11-20 08:20:33
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Zhu, H. et al. Novel biomimetic mesoporous silica nanoparticle system possessing targetability and immune synergy facilitates effective solid tumor immuno-chemotherapy. Biomater. Adv. 144, 213229 (2023). Article CAS PubMed Google Scholar

Silica vs Silicone: Key Differences in Structure, Properties and Uses

Silica as an Anti-Caking Agent: How It Works and Where It Is Used
Silica Wholesale: How to Buy in Bulk and Get the Best Price
Yue, J. et al. Light-triggered multifunctional nanoplatform for productive cancer photo-immunotherapy. J. Nanobiotechnol. 20, 1-16 (2022). Article Google Scholar
Ultrafine Silica Powder: Particle Sizes, Specifications and Applications
Targeted delivery tactics are generally divided into two categories: passive targeting and active targeting. Passive targeting relies on the pathological qualities of the disease microenvironment and the nature of the drug delivery system itself, which allows the drug to effectively accumulate at the lesion site of disease. The most well-known passive targeting is the EPR effect of tumor, which refers to the phenomenon that some particles with particular size (20-200 nm) penetrate more without difficulty into tumor tissue and remain there for a long time when compared to normal tissue. 316, 317 Therefore, controlling the size of MSNs to a fitting range will facilitate their enrichment in the tumor sites. However, it has also been highlighted that the passive targeting strategy relying on the EPR effect can attain only 0.7% of the injected NPs enrichment in solid tumors, 318 which will not be handy for the clinical translation of nanotechnology. In contrast, active targeting relies on the active recognition between the molecules on the NPs surface and the specific molecules or proteins in the illness microenvironment, which is also referred to as ligand-receptor specific binding. 319 The active targeting shows a higher drug delivery efficiency compared to passive targeting. 320 Targeted ligands, such as proteins, antibodies, peptides, nucleic acids and chemical tiny molecules, can be modified on the surface of MSNs, and the modified MSNs are capable of selectively aggregating at the lesion site based on the powerful affinity between the targeted ligands and the particular receptors overexpressed in the sickness microenvironment. 321, 322, 323, 324 For instance, compared to mature vascular endothelial cells, tumor neovascular endothelial cells are highly expressed in an array of proteins, such as integrins, transmembrane glycoproteins and aminopeptidase N. Molecules that recognize these highly expressed proteins can be used for neovascular-based targeted drug delivery. A standard example is that arginylglycylaspartic acid (RGD)-modified MSNs can selectively bind integrin α ν β 3 receptor and hence be applied to target tumor neovascularization. 325
Evonik Aerosil: Product Range, Key Grades and Equivalent Alternatives
Chen, F. et al. In vivo tumor vasculature targeting of CuS@MSN based theranostic nanomedicine. ACS Nano 9, 3926-3934 (2015). Article CAS PubMed Central PubMed Google Scholar

What Is Highly Dispersible Silica (HDS)? Benefits for Tire Performance Explained

What is silica (SiO₂)?

silicon dioxide manufacturer Conclusion and perspective

What is the difference between fumed silica and precipitated silica?

silica supplier UAE The common thermal therapy tactics include PTT and magnetothermal therapy (MTT). The integration of some certain functional factors into the MSNs can induce photothermal or magnetothermal influences by external light irradiation or by applying a magnetic field, respectively. During the thermal therapy, the locally generated thermal impact can cause irreversible damage to cells or tissues at the lesion, hence attaining targeted, non-invasive treatment. Regarding PTT, organic photothermal agents (PTAs) such as phthalocyanines and porphyrins can convert light energy into heat energy through non-radiative forms of decay-vibrational relaxation, 387, 388 as well as inorganic PTAs such as noble metals achieve photothermal conversion through LSPR effect, 389, 390 to produce the temperature needed for treatment. The single MSNs-based PTT modality has been thoroughly studied, and the current research focuses on the construction of integrated nanoplatform for diagnosis and treatment, or the development of multimodal synergistic treatment strategies. 391 A recent study reported by Kadria-Vili et al. demonstrated that MSNs could encapsulate Gd 2 O 3 NPs for dual T 1 /T 2 contrast and Au nanoshell PTA for NIR light-responsive PTT, thus giving clinicians the talent to " and treat". 392 In addition, MSNs were considered as a biocompatible and multifunctional nanoplatform for photothermal-immunotherapy against melanoma tumors, through merely integrating polydopamine PTA, ovalbumin model antigen, and ammonium bicarbonate antigen release promoter. 393 PTT suffers from insufficient penetration depth of NIR light, resulting in decreased treatment efficiency. In contrast, MTT can kill deep tumor cells by increasing the temperature to 43-48 °C, without causing significant side impacts to surrounding normal cells. 394 During the action, the magnetic NPs act as thermoseeds, exposed to an alternating magnetic field, absorbing magnetic energy and dissipating thermal energy through the magnetic relaxation influence. 395, 396 In a study reported by Yao et al., MSNs-based nanoplatform was proven to achieve synergistic therapeutic influence of PTT and MTT. They used MSNs shell to coat magnetic Fe 3 O 4, and served graphene quantum dots with photothermal conversion ability as the cap to control DOX release. After reaching the tumor acidic microenvironment and applying external light and magnetic field stimuli, DOX was released in a controlled manner and the accelerated tumor hyperthermia was attained. 397 In addition to PTT and MTT, the MSNs-mediated radiofrequency thermotherapy is also reported. Especially, the Si NPs themselves can serve as an excellent sensitizer to enhance the radiofrequency radiation effect. 398 A study by Tamarov et al. demonstrated that the radiofrequency radiation could more efficiently trigger temperature-responsive drug release than infrared light, therefore inhibiting tumor cell expansion even after one treatment. 399

What drives silica raw material prices?

silica stocks Mesoporous silica nanoparticles (MSNs) are recognized as a prime example of nanotechnology applied in the biomedical field, owing to their readily tunable structure and composition, various surface functionalization properties, and excellent biocompatibility. Over the past two decades, researchers have developed a wide range of MSNs-based nanoplatforms through careful design and controlled preparation approaches, demonstrating their adaptability to diverse biomedical application scenarios. With the continuous breakthroughs of MSNs in the fields of biosensing, disease diagnosis and treatment, tissue engineering, etc., MSNs are steadily moving from basic research to clinical trials. In this review, we supply a detailed summary of MSNs in the biomedical field, beginning with a comprehensive overview of their expansion history. We then discuss the types of MSNs-based nanostructured architectures, along with the classification of MSNs-based nanocomposites according to the elements existed in diverse inorganic functional factors. Subsequently, we summarize the primary purposes of surface-functionalized modifications of MSNs. In the following, we examine the biomedical applications of MSNs, and highlight the MSNs-based targeted therapeutic modalities currently developed. Given the importance of clinical translation, we also summarize the progress of MSNs in clinical trials. Lastly, we take a perspective on the future direction and remaining difficulties of MSNs in the biomedical field.

Cite this article: Silica Raw Materials News. "Silica Manufacturer in China: How to Evaluate Quality, Capacity and Export Experience ." Published 2026-11-20 08:20:33. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.